The DOI matches its Crossref record.
Clinical Status of Anti-Cancer Agents Derived from Marine Sources
Abstract
The chemical, biological and ecological diversity of the marine ecosystem has contributed immensely in the discovery of extremely potent compounds that have shown potent activities in antitumor, analgesia, antiinflammatory, immunomodulation, allergy, anti-viral etc. The compounds of marine origin are diverse in structural class from simple linear peptides to complex macrocyclic polyethers. The recent advances in the sophisticated instruments for the isolation and characterization of marine natural products and development of high-throughput screening, have substantially increased the rate of discovery of various compounds of biomedical application. Didemnin was the first marine peptide that entered in human clinical trials in US for the treatment of cancer and other compounds such as dolastatin-10, soblidotin, didemnin B, ecteinascidin 743, girolline, aplidine, cryptophycins (also arenastatin A), bryostatin 1, ILX 651, kahalalide F, E7389, discodermolide, ES-285 (spisulosine), HTI-286 (hemiasterlin derivative), squalamine, KRN-7000, vitilevuamide, Laulimalide, Curacin A, diazonamide, peloruside A, eleutherobin, sarcodictyin, thiocoraline, salicylihalimides A, ascididemnin, CGX-1160, CGX-1007dictyodendrins, GTS-21 (aka DMBX), manoalide, IPL-576,092 (aka HMR-4011A) have entered in the clinical trials. This article summarize clinical status and synthetic advances of some of these compounds. Keywords: Dolastatin-10, Ecteinascidin 743, Girolline, Bryostatin 1, Kahalalide F, Discodermolide, Squalamine, KRN-7000, Laulimalide, Thiocoraline
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, neovastat stops the binding of VEGF to its receptor [227,229].”
From Marine Natural Products: A Source of Novel Anticancer Drugs (2019) · cites this paper as [227]
In the citing paper
“Aplidine displays promising anti-proliferative activity (currently in phase I–II trials) via characterized delay of neuromuscular toxicity and promising anti-proliferative activity (Figure 8) [227].”
From Marine Natural Products: A Source of Novel Anticancer Drugs (2019) · cites this paper as [227]
Citations
Cited by
Sorted by citations
Marine Natural Products: A Source of Novel Anticancer Drugs
Khalifa, S. A. M., Elias, N., Farag, M. A., Chen, L., Saeed, A., Hegazy, M.-E. F., Moustafa, M. S., Abd El-Wahed, A., Al-Mousawi, S. M., Musharraf, S. G., et al. (2019) · Marine Drugs · doi:10.3390/md17090491 · Cited by 555
Marine Natural Products: A New Wave of Drugs?
Montaser, R., & Luesch, H. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.118 · Cited by 457
Mehbub, M. F., Lei, J., Franco, C. M. M., & Zhang, W. Y. (2014) · Marine Drugs · doi:10.3390/md12084539 · Cited by 425
Blunt, J. W., Copp, B. R., Munro, M. H. G., Northcote, P. T., & Prinsep, M. R. (2010) · Natural Product Reports · doi:10.1039/b906091j · Cited by 409
Tubulin-Interactive Natural Products as Anticancer Agents
Kingston, D. G. I. (2009) · Journal of Natural Products · doi:10.1021/np800568j · Cited by 341
Antibody Drug Conjugates for Cancer Therapy
Polakis, P. G. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009373 · Cited by 315
Biosynthesis of polyketides by trans-AT polyketide synthases
Piel, J. (2010) · Natural Product Reports · doi:10.1039/b816430b · Cited by 304
Natural products for treating colorectal cancer: A mechanistic review
Huang, X., Yang, Z., Xie, Q., Zhang, Z., Zhang, H., & Ma, J. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109142 · Cited by 233
Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy
Chen, H., Lin, Z., Arnst, K. E., Miller, D. D., & Li, W. (2017) · Molecules · doi:10.3390/molecules22081281 · Cited by 221
Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides
Mulder, K. C. L., de Lima, L. A., Miranda, V. D. J., Dias, S. C., & Franco, O. L. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00321 · Cited by 212
Al‐Mourabit, A., Zancanella, M. A., Tilvi, S., et al. (2011) · Natural Product Reports · doi:10.1039/c0np00013b · Cited by 195
Invertebrate Models for Biomedical Research, Testing, and Education
Wilson-Sanders, S. E. (2011) · ILAR Journal · doi:10.1093/ilar.52.2.126 · Cited by 139
Pettit, R. K. (2010) · Marine Biotechnology · doi:10.1007/s10126-010-9294-y · Cited by 131
Current Screening Methodologies in Drug Discovery for Selected Human Diseases
Lage, O. M., Ramos, M. C., Calisto, R., Almeida, E., Vasconcelos, V. M., & Vicente, F. (2018) · Marine Drugs · doi:10.3390/md16080279 · Cited by 139
The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics
Gerber, H., Koehn, F. E., & Abraham, R. T. (2013) · Natural Product Reports · doi:10.1039/c3np20113a · Cited by 97
Microtubule-stabilizing agents: New drug discovery and cancer therapy
Zhao, Y., Mu, X. L., & Du, G. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.12.006 · Cited by 83
Gao, G., Wang, Y., Hua, H., Li, D., & Tang, C. (2021) · Marine Drugs · doi:10.3390/md19070363 · Cited by 88
Recent Advances in Small Peptides of Marine Origin in Cancer Therapy
Zhang, Q., Liu, Z.-D., Wang, Z., Wang, T., Wang, N., Wang, N., Zhang, B., & Yu-fen, Z. (2021) · Marine Drugs · doi:10.3390/md19020115 · Cited by 76
Leone, A., Lecci, R. M., Durante, M., & Piraino, S. (2013) · Marine Drugs · doi:10.3390/md11051728 · Cited by 73
Origins and Bioactivities of Natural Compounds Derived from Marine Ascidians and Their Symbionts
Dou, X., & Dong, B. (2019) · Marine Drugs · doi:10.3390/md17120670 · Cited by 72
Oskuei, S. R., Mirzaei, S., Jafari-Nik, M. R., et al. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104904 · Cited by 70
Microtubule-Stabilizing Drugs from Marine Sponges: Focus on Peloruside A and Zampanolide
Miller, J. H., Singh, A. J., & Northcote, P. T. (2010) · Marine Drugs · doi:10.3390/md8041059 · Cited by 67
New Perspectives on Innovative Drug Discovery: An Overview
Pan, S. Y., Pan, S. L., Yu, Z., Ma, D., Chen, S., Fong, W. F., Han, Y., & Ko, K. (2010) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j39w2g · Cited by 65
Ciavatta, M. L., Lefranc, F., Carbone, M., Mollo, E., Gavagnin, M., Betancourt, T., Dasari, R., Kornienko, A., & Robert Kiss, A. (2016) · Medicinal Research Reviews · doi:10.1002/med.21423 · Cited by 67
Bilal, M., & Iqbal, H. M. N. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.02.037 · Cited by 62
Marine Compounds and Cancer: Where Do We Stand?
Dyshlovoy, S. A., & Honecker, F. U. (2015) · Marine Drugs · doi:10.3390/md13095657 · Cited by 56
Wang, H., Tang, J., Wang, Y., et al. (2019) · Cancers · doi:10.3390/cancers11091303 · Cited by 51
Natural product mode of action (MOA) studies: a link between natural and synthetic worlds
Clair, J. J. L. (2010) · Natural Product Reports · doi:10.1039/b909989c · Cited by 48
Bioactive Compounds from Marine Heterobranchs
Àvila, C., & Angulo‐Preckler, C. (2020) · Marine Drugs · doi:10.3390/md18120657 · Cited by 48
Amarante, G. W., Cavallaro, M., & Coelho, F. (2010) · Tetrahedron Letters · doi:10.1016/j.tetlet.2010.02.169 · Cited by 41
Jing, Q., Hu, X., Ma, Y.-Z., Mu, J., Liu, W., Xu, F., Li, Z., Bai, J., Hua, H., & Li, D. (2019) · Marine Drugs · doi:10.3390/md17070384 · Cited by 40
Molecular mechanisms of action of Trehalose in cancer: A comprehensive review
Chaitanya, N. S. N., Devi, A., Sahu, S., & Alugoju, P. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118968 · Cited by 37
Hill, R. A. (2009) · Annual Reports Section B (Organic Chemistry) · doi:10.1039/b822053k · Cited by 38
Buchholz, T. J., Rath, C. M. B., Lopanik, N. B., Gardner, N. P., Håkansson, K., & Sherman, D. H. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.08.008 · Cited by 37
The Phylum Bryozoa: From Biology to Biomedical Potential
Ciavatta, M. L., Lefranc, F., Vieira, L. M., Robert Kiss, A., Carbone, M., van Otterlo, W. A. L., Lopanik, N. B., & Waeschenbach, A. (2020) · Marine Drugs · doi:10.3390/md18040200 · Cited by 36
Diastereoselective synthesis and bioactivity of long-chain anti-2-amino-3-alkanols
Chen, B., Yang, L., Ye, J., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.09.010 · Cited by 35
Sugumaran, A., Pandiyan, R., Kandasamy, P., Antoniraj, M. G., Navabshan, I., Balasubramaniyan, S., Dharmaraj, S., Chinnaiyan, S. K., Ashokkumar, V., & Ngamcharussrivichai, C. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.155445 · Cited by 36
DeChristopher, B. A., Fan, A. C., Felsher, D. W., & Wender, P. A. (2012) · Oncotarget · doi:10.18632/oncotarget.438 · Cited by 36
Cultivation-independent approaches to investigate the chemistry of marine symbiotic bacteria
Uria, A. R., & Piel, J. (2009) · Phytochemistry Reviews · doi:10.1007/s11101-009-9127-7 · Cited by 34
Wang, X., Mao, Z.-G., Song, B., Chen, C., Xiao, W., Hu, B., Wang, J., Jiang, X., Zhu, Y., & Wang, H. (2013) · Marine Drugs · doi:10.3390/md11103601 · Cited by 34
Research Progress on bioactive peptides from animal sources: A comprehensive review
Sun, J., Chen, Y., Yang, Y., Chen, H., Zhang, J., Wang, H., Bai, D., Sun, Z., Song, J., & Dai, L. (2025) · Food Chemistry · doi:10.1016/j.foodchem.2025.145006 · Cited by 35
An Approach to the Bis-oxazole Macrocycle of Diazonamides
Zhang, J., & Ciufolini, M. A. (2010) · Organic Letters · doi:10.1021/ol102678j · Cited by 33
Ecoy, G. A. U., Chamni, S., Suwanborirux, K., Chanvorachote, P., & Chaotham, C. (2019) · Journal of Natural Products · doi:10.1021/acs.jnatprod.9b00102 · Cited by 32
Tao, L.-Y., Zhang, J., Liang, Y.-J., Chen, L., Zheng, L.-S., Wang, F., Mi, Y., She, Z., To, K. K. W., Lin, Y., et al. (2010) · Marine Drugs · doi:10.3390/md8041094 · Cited by 31
Optimization of Marine Triterpene Sipholenols as Inhibitors of Breast Cancer Migration and Invasion
Foudah, A. I., Jain, S. K., Busnena, B. A., & Sayed, K. A. E. (2013) · ChemMedChem · doi:10.1002/cmdc.201200516 · Cited by 31
A Shimizu Non‐Aldol Approach to the Formal Total Synthesis of Palmerolide A
Pujari, S. A., Parthasarathy, G., & Kaliappan, K. P. (2011) · Chemistry - An Asian Journal · doi:10.1002/asia.201100429 · Cited by 29
Zhang, N., Zhong, R., Yan, H., & Jiang, Y. (2010) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2010.01069.x · Cited by 28
Marine-Derived Metabolites of S-Adenosylmethionine as Templates for New Anti-Infectives
Sufrin, J. R., Finckbeiner, S., & Oliver, C. M. (2009) · Marine Drugs · doi:10.3390/md7030401 · Cited by 27
Asymmetric Synthesis of ES‐285, an Anticancer Agent Isolated from Marine Sources
Allepuz, A. C., Badorrey, R., Diaz-De-Villegas, M. D., et al. (2009) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200900828 · Cited by 27
Finding chemo: the search for marine-based pharmaceutical drugs active against cancer
Indumathy, S., & Dass, C. R. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12097 · Cited by 26
Anti-Melanogenic Property of Geoditin A in Murine B16 Melanoma Cells
Cheung, F. W. K., Guo, J., Ling, Y. H., et al. (2012) · Marine Drugs · doi:10.3390/md10020465 · Cited by 26
3‐(2,4‐Dimethoxybenzylidene)‐anabaseine: A promising candidate drug for Alzheimer's disease?
Zawieja, P. P., Kornprobst, J., & Métais, P. (2012) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2011.00827.x · Cited by 25
Natural products as probes in pharmaceutical research
Schmitt, E. K., Hoepfner, D., & Krastel, P. (2015) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-015-1691-9 · Cited by 24
Harmful and beneficial properties of cyanotoxins: Two sides of the same coin
Ricciardelli, A., Pollio, A., Costantini, M., & Zupo, V. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108235 · Cited by 26
Asymmetric total syntheses of spisulosine, its diastereo- and regio-isomers
Dinda, S. K., Das, S. K., & Panda, G. (2010) · Tetrahedron · doi:10.1016/j.tet.2010.09.018 · Cited by 23
Separacenes A–D, Novel Polyene Polyols from the Marine Actinomycete, Streptomyces sp.
Bae, M., Kim, H., Shin, Y., Kim, B., Lee, S. K., Oh, K., Shin, J., & Oh, D. (2013) · Marine Drugs · doi:10.3390/md11082882 · Cited by 23
Muigg, P., Rosén, J., Bohlin, L., & Backlund, A. (2013) · Phytochemistry Reviews · doi:10.1007/s11101-012-9256-2 · Cited by 22
Advances in the Total Syntheses of Complex Indole Natural Products
Fu, L. (2010) · Topics in heterocyclic chemistry · doi:10.1007/7081_2010_49 · Cited by 22
A New in Vitro Anti-Tumor Polypeptide Isolated from Arca inflata
Xu, J., Chen, Z., Song, L., Chen, L., Zhu, J., Lv, S., & Yu, R. (2013) · Marine Drugs · doi:10.3390/md11124773 · Cited by 21
Foudah, A. I., Sallam, A. A., Akl, M. R., & Sayed, K. A. E. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.11.039 · Cited by 21
Palem, J. R., Mudit, M., Hsia, S. V., & Sayed, K. A. E. (2016) · Zeitschrift für Naturforschung C · doi:10.1515/znc-2016-0080 · Cited by 21
Extremophiles and their application to veterinary medicine
Irwin, J. A. (2010) · Environmental Technology · doi:10.1080/09593330.2010.484073 · Cited by 22
A New Scaffold of an Old Protein Fold Ensures Binding to the Bisintercalator Thiocoraline
Biswas, T., Zolova, O. E., Lombó, F., et al. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.01.053 · Cited by 20
Tomašič, T., Nabergoj, D., Vrbek, S., et al. (2014) · MedChemComm · doi:10.1039/c4md00286e · Cited by 19
Impact of Marine Drugs on Cytoskeleton-Mediated Reproductive Events
Silvestre, F., & Tosti, E. (2010) · Marine Drugs · doi:10.3390/md8040881 · Cited by 19
Novel Bioactive Peptides from Cyanobacteria
Arif, J. M., Farooqui, A., Siddiqui, M. H., Al-Karrawi, M., Al-Hazmi, A., & Al‐Sagair, O. A. (2012) · Studies in natural products chemistry · doi:10.1016/b978-0-444-53836-9.00022-0 · Cited by 17
Pettit, G. R., Smith, T. H., Xu, J., Herald, D. L., Flahive, E. J., Anderson, C. R., Belcher, P. E., & KNIGHT, J. C. (2011) · Journal of Natural Products · doi:10.1021/np100877h · Cited by 17
Dembitsky, V. M. (2022) · Hydrobiology · doi:10.3390/hydrobiology1030024 · Cited by 17
Xenicane Natural Products: Biological Activity and Total Synthesis
Betschart, L., & Altmann, K. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666151002112607 · Cited by 16
Jimenez, P. C., Ferreira, E. G., Araújo, L. A., Guimarães, L. A., Sousa, T. S., Pessoa, O. D. L., Lotufo, T. M. D. C., & Costa-Lotufo, L. V. (2017) · Latin American Journal of Aquatic Research · doi:10.3856/vol41-issue2-fulltext-12 · Cited by 18
Geoditin A Induces Oxidative Stress and Apoptosis on Human Colon HT29 Cells
Cheung, F. W. K., Li, C., Che, C., et al. (2010) · Marine Drugs · doi:10.3390/md8010080 · Cited by 16
Targets and Therapeutic Properties
Beeton, C. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-385095-9.00064-6 · Cited by 15
Marine Sponge-Derived/Inspired Drugs and Their Applications in Drug Delivery Systems
Ramanjooloo, A., Andersen, R. J., & Bhaw‐Luximon, A. (2021) · Future Medicinal Chemistry · doi:10.4155/fmc-2020-0123 · Cited by 15
Ali‐Seyed, M., & Ayesha, S. (2021) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-021-00350-z · Cited by 18
Antiproliferative effect of flavomannin-6,6′-dimethylether from Tricholoma equestre on Caco-2 cells
Pachón-Peña, G., Reyes‐Zurita, F. J., Deffieux, G., et al. (2009) · Toxicology · doi:10.1016/j.tox.2009.08.009 · Cited by 14
Juneja, M., Vanam, U., Sripriya, P., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.02.032 · Cited by 13
Synthesis and use of dioxime ligands for treatment of leukemia and colon cancer cells
Babahan, I., Özmen, A., & Aslan, K. (2017) · Applied Organometallic Chemistry · doi:10.1002/aoc.3752 · Cited by 13
Synthesis and anti-tumor activity of marine alkaloids
Zhou, S., Huang, G., & Chen, G. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.128009 · Cited by 12
Lai, K.-H., Peng, B., Hsu, Y., et al. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105150 · Cited by 11
Choi, M., Lee, J., Nam, S., et al. (2017) · Marine Drugs · doi:10.3390/md15090279 · Cited by 11
Peng, S., Tang, J., Lan, T., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043987 · Cited by 10
Potential Role of Marine Species-Derived Bioactive Agents in the Management of SARS-CoV-2 Infection
Asif, M., Saleem, M., Yaseen, H. S., Yehya, A. H. S., Saadullah, M., Zubair, H. M., Oon, C. E., Khaniabadi, P. M., Khalid, S. H., Khan, I. U., et al. (2021) · Future Microbiology · doi:10.2217/fmb-2021-0024 · Cited by 10
Zhou, S., & Huang, G. (2020) · RSC Advances · doi:10.1039/d0ra05856d · Cited by 10
RetractedNew Medical Applications of Plant Secondary Metabolites
Heilmann, J. (2010) · Wiley-Blackwell eBooks · doi:10.1002/9781444318876.ch5 · Cited by 10
Total synthesis of marine natural products separacenes A and B
Das, S., & Goswami, R. K. (2017) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob00345e · Cited by 9
From Sea Sponge to Clinical Trials: Starting the Journey of the Novel Compound PM742
Cruz, P. G., Fernández, R., Rodríguez‐Acebes, R., et al. (2024) · Marine Drugs · doi:10.3390/md22080339 · Cited by 8
Synthesis of a triterpene-spermidine conjugate
Kazakova, O. B., Giniyatullina, G. V., Medvedeva, N. I., et al. (2012) · Russian Journal of Organic Chemistry · doi:10.1134/s1070428012100181 · Cited by 8
Girolline is a sequence context-selective modulator of eIF5A activity
Schneider‐Poetsch, T., Dang, Y., Iwasaki, W., Arata, M., Shichino, Y., Al‐Mourabit, A., Moriou, C., Romo, D., Liu, J. O., Ito, T., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-54838-2 · Cited by 7
Shiau, J., Chuang, Y.-T., Tang, J., Chen, S., Hou, M., Jeng, J., Cheng, Y., & Chang, H. (2022) · Antioxidants · doi:10.3390/antiox11101982 · Cited by 7
Natural Anticancer Compounds and Their Derivatives in Clinical Trials
Veerabhadrappa, B., Sudharshan, S. J., & Dyavaiah, M. (2017) · Springer eBooks · doi:10.1007/978-981-10-8216-0_3 · Cited by 8
Natural Product Cytotoxins as Payloads for Antibody Drug Conjugates
Koehn, F. E. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4654-5_5 · Cited by 7
Pharmacological Applications of Metabolites of Mangrove Endophytes: A Review
Das, S. K., Samantray, D., & Thatoi, H. (2018) · Springer eBooks · doi:10.1007/978-981-10-7140-9_16 · Cited by 7
Youssef, D. T. A., Shaala, L. A., Almohammadi, A. M., et al. (2021) · Letters in Organic Chemistry · doi:10.2174/1570178618666210617112441 · Cited by 5
Identification and validation of a novel anoikis‐related prognostic model for prostate cancer
Zhang, P., Lv, W., Luan, Y., Cai, W., Min, X., & Feng, Z. (2024) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.2419 · Cited by 5
Marine Compounds as a Starting Point to Drugs
Rubiolo, J. A., Alonso, E., & Cagide, E. (2014) · CRC Press eBooks · doi:10.1201/b16662-48 · Cited by 5
Auristatin Payloads for Antibody–Drug Conjugates (ADCs)
Doronina, S. O., & Senter, P. D. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788012898-00073 · Cited by 5
Foudah, A. I., Sallam, A. A., & Sayed, K. A. E. (2014) · Springer eBooks · doi:10.1007/978-3-319-07145-9_26 · Cited by 5
Huang, Y.-C., Chiang, L., Chang, K.-S., et al. (2012) · Molecules · doi:10.3390/molecules17033058 · Cited by 4
Ismail, M., Hassan, M. H. A., Zaki, M., et al. (2022) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2022.121111 · Cited by 4
Synthesis of an Acyclic C1–C11 Fragment of Peloruside B
Zang, Q., Gulab, S. A., Stocker, B. L., Baars, S. M., & Hoberg, J. O. (2011) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201100053 · Cited by 4
Metadata
- Authors
- Singh, R., Sharma, M., Joshi, P., & Rawat, D.
- Affiliations
- University of Delhi (IN)
- Corresponding author
- Rawat, Diwan
- Venue
- Anti-Cancer Agents in Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2008-08-01
- Volume
- 8
- Issue
- 6
- Pages
- 603-617
- ISSN
- 1568-0118 (ISSN-L)
- 1871-5206
- OpenAlex
- W4234505122
- Cited by
- 143
- References
- 0
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 12 · 2020: 8 · 2019: 9 · 2018: 5 · 2017: 8 · 2016: 4 · 2015: 5 · 2014: 8 · 2013: 14 · 2012: 8
- FWCI
- 11.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Anti-Cancer Agents in Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Marine Sponges and Natural Products
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Physical Sciences › Chemistry › Organic Chemistry › Isoquinoline Alkaloid Synthesis
- Keywords
- marine natural products, anticancer agents, clinical trials, marine peptides, dolastatin 10, trabectedin, bryostatin 1, kahalalide F, discodermolide, squalamine, laulimalide, synthetic analogues
- MeSH terms
- Animals, Antineoplastic Agents, Bacteria, Biological Products, Clinical Trials as Topic, Drug Evaluation, Preclinical, Humans, Invertebrates, Marine Biology, Models, Biological, Neoplasms, Oceans and Seas
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review